ECS vs PHX

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

ECS

ECSBOTANIC FPO [ECS]

44LOW

PHX

PHARMX FPO [PHX]

44LOW

Score Breakdown

ECS PHX
Technical
51
43
Catalyst
51
60
Sentiment
50
50
Fundamental
42
74
Momentum
51
73
Risk Gate
27
50

Key Metrics

ECS Metric PHX
$8.0MMarket Cap$65.9M
1.2MAvg Volume (20d)741K
N/AShort InterestN/A
$0.01452-Week High$0.200
$0.00452-Week Low$0.066
+0.0%Daily Change-4.8%
$0.005Entry Price$0.100
-18.3%ROE-5.9%
-21.9%Profit Margin-12.2%

Active Signals

ECS Signals

RSI drifting toward oversold territory — worth watching
Stochastic just turned bullish from a low level — early reversal sign
Trading below both moving averages — the trend is working against this one
Volume surging at 9.1x normal while price falls — heavy selling pressure
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.5 quarters)
Low P/S ratio (0.4x)

PHX Signals

RSI drifting toward oversold territory — worth watching
Stochastic just turned bullish from a low level — early reversal sign
Trading below both moving averages — the trend is working against this one
Drifting lower — down 9.1% over the last 5 days
Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive

Ask Scout AI to compare ECS and PHX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
ECS Full Analysis → PHX Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).